SIFI > Contacts


General questions
info@sifigroup.com
 

Products Quality
QualityUnit@sifigroup.com
     
Pharmacovigilance
pharmacovigilance@sifigroup.com
  Vigilance on Medical devices
dispositivovigilanza@sifigroup.com
     
Vigilance on Surgical devices
customer.surgical@sifigroup.com
  Press and social media
press@sifigroup.com


Human Resources
sviluppo.organizzativo@sifigroup.com

 
Medical Information
medicalinformation@sifigroup.com
“Vision is the art of seeing what is invisible to others.”
Jonathan Swift

 
 
Disclosure of Transfers of value    SIFI is a pharmaceutical company committed to fulfilling the needs of its customers, both patients and ophthalmologists.   SIFI strongly...
 
Vision & History Established in 1935 by two local pharmacists in Sicily, SIFI started as a venture, specializing in the preparation of ophthalmic products. Since then, research, development,...
 
SIFI Group has a Vigilance system that allows us to take full responsibility for our medical and non medical products, both marketed or in clinical development and to take appropriate...

On our Social Channels

From our News Center

MINI WELL READY, an innovative lens for the surgical correction of presbyopia has been registered and approved by the South Korean Ministry of Food & Drug Safety.   SIFI, Italian leader...
 

 

12 July

ATLANTA, July 12, 2017 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in the commercialization, research, and development of prescription ophthalmic...
Follow Us!